About Mabel Pharmaceuticals
Mabel Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing, research, and services focused on global healthcare in India. Its Indian entity Mabel Pharmaceuticals Private Limited reported revenue of ₹23.9 Lakh. Mabel Pharmaceuticals offers products and services including Pharmaceutical Products and Research and Innovation Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic and Innovative Drugs and Research and Development.
Company details
Mabel Pharmaceuticals is recognized as a client-centric organization where ethical business policies are observed to foster reliability and trust. Quality assurance systems are established to implement preventive measures and train workforces effectively, ensuring objectives are met. A focused approach is adopted to serve global healthcare needs through empathy, innovation, and technology, with an understanding of customer requirements driving the use of cutting-edge solutions. Research and development are emphasized as key strategies for achieving competitive advantages, while commitments to excellence and customer satisfaction are upheld through extensive experience and documentation of essential steps.
- SectorsHealthcare
- Email••••••••
- Website mabelpharmaceuticals.com
- Social LinkedIn X
- Legal Name Mabel Pharmaceuticals Pvt. Ltd
- Date of Incorporation 27 Apr, 2016
- Jurisdiction Haridwar, Uttarakhand, India
- Indian entity revenue₹23.9 Lakh
FY 2024 · -52% YoY
- Indian entity net profit₹34,898
FY 2024 · 1% margin
- Indian entity EBITDA₹1.2 Lakh
FY 2024 · 5% margin
Associated legal entities of Mabel Pharmaceuticals
Mabel Pharmaceuticals operates through Mabel Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mabel Pharmaceuticals Private Limited CIN U74999UR2016PTC007023 | Active | 27 Apr 2016 | Haridwar, Uttarakhand | ₹0.2 Cr | 3 | View details |
Products & Services of Mabel Pharmaceuticals
Mabel Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Research and Innovation Services.
Pharmaceutical products are manufactured and supplied to meet global healthcare needs with an emphasis on innovation and quality.
Research and innovation services are provided to support competitive advantages in the pharmaceutical sector.
Board of directors of Mabel Pharmaceuticals Private Limited (Mabel Pharmaceuticals)
Mabel Pharmaceuticals Private Limited is the primary company behind Mabel Pharmaceuticals. The board of Mabel Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Naveen Chandra Pant, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Naveen Chandra Pant DIN 07449743 | Director | 27 Apr 2016 | 10 yrs 6 mo | Mabel Pharmaceuticals Private Limited |
| Kamal Kishor DIN 07449740 | Director | 27 Apr 2016 | 10 yrs 6 mo | Mabel Pharmaceuticals Private Limited |
| Naresh Kumar Pant DIN 10397854 | Director | 20 Nov 2023 | 2 yrs 11 mo | Mabel Pharmaceuticals Private Limited |
Financials of Mabel Pharmaceuticals
Figures of Mabel Pharmaceuticals Private Limited, the primary company behind Mabel Pharmaceuticals, for FY 2024. Revenue was ₹23.9 Lakh (-52% year on year). Net profit was ₹34,898 (1% margin). EBITDA was ₹1.2 Lakh (5% margin). Revenue has grown at a compounded annual rate of +11% over three years and -1% over five years.
- ₹23.9 LakhRevenue · FY 2024 · -52% YoY
- ₹34,898Net profit · 1% margin
- ₹1.2 LakhEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- +11%Revenue CAGR, 3 years
- -1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mabel Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Mabel Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mabel Pharmaceuticals
The primary company behind Mabel Pharmaceuticals, Mabel Pharmaceuticals Private Limited, reported revenue of ₹23.9 Lakh for FY 2024, down 52% year on year.
Mabel Pharmaceuticals is recognized as a client-centric organization where ethical business policies are observed to foster reliability and trust. Quality assurance systems are established to implement preventive measures and train workforces effectively, ensuring objectives are met. A focused approach is adopted to serve global healthcare needs through empathy, innovation, and technology, with an understanding of customer requirements driving the use of cutting-edge solutions. Research and development are emphasized as key strategies for achieving competitive advantages, while commitments to excellence and customer satisfaction are upheld through extensive experience and documentation of essential steps.
Mabel Pharmaceuticals offers Pharmaceutical Products and Research and Innovation Services.
Mabel Pharmaceuticals operates through Mabel Pharmaceuticals Private Limited.
The legal entities of Mabel Pharmaceuticals currently have 3 directors, including Naresh Kumar Pant, Naveen Chandra Pant, Kamal Kishor.